1-3 of 3
Felice C. Lightstone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract ND07: BBO-8520, a first-in-class, direct inhibitor of KRASG12C (ON), locks GTP-bound KRASG12C in the state 1 conformation resulting in rapid and complete blockade of effector binding

Anna E. Maciag, James Stice, Bin Wang, Alok Sharma, Albert Chan, Ken Lin, Devansh Singh, Marcin Dyba, Yue Yang, Saman Setoodeh, Brian P. Smith, Dana Rabara, Zuhui Zhang, Erik K. Larsen, Dom Esposito, John Paul Denson, Michela Ranieri, Mary Meynardie, Sadaf Mehdizadeh, Patrick Alexander, Maria Abreu Blanco, David Turner, Rui Xu, Felice C. Lightstone, Kwok Kin Wong, Dhirendra Simanshu, Keshi Wang, Andrew G. Stephen, Kerstin Sinkevicius, Dwight V. Nissley, Eli Wallace, Frank McCormick, Pedro J. Beltran
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): ND07.
https://doi.org/10.1158/1538-7445.AM2024-ND07
Published: 05 April 2024
View article titled, Abstract ND07: BBO-8520, a first-in-class, direct inhibitor of KRASG12C (ON), locks GTP-bound KRASG12C in the state 1 conformation resulting in rapid and complete blockade of effector binding
Journal Articles

Halogenated Benzimidazole Carboxamides Target Integrin α4β1 on T-Cell and B-Cell Lymphomas

Richard D. Carpenter, Arutselvan Natarajan, Edmond Y. Lau, Mirela Andrei, Danielle M. Solano, Felice C. Lightstone, Sally J. DeNardo, Kit S. Lam, Mark J. Kurth
Journal: Cancer Research
Cancer Res (2010) 70 (13): 5448–5456.
https://doi.org/10.1158/0008-5472.CAN-09-3736
Published: 30 June 2010
View article titled, Halogenated Benzimidazole Carboxamides Target Integrin α<sub>4</sub>β<sub>1</sub> on T-Cell and B-Cell Lymphomas
Open the PDF for Halogenated Benzimidazole Carboxamides Target Integrin α<sub>4</sub>β<sub>1</sub> on T-Cell and B-Cell Lymphomas in another window
Includes: Supplementary data
Journal Articles

Development of synthetic high affinity ligands that bind to a structural epitope on the tumor cell receptor HLA-DR10

Rod Balhorn, Julie Perkins, Patricia A. Burke, Felice C. Lightstone, Monique Cosman, Ceslovas Venclovas, Michele Corzett, Sally J. Denardo, Terry A. Lehner, Jeff P. Gregg, Huguette Albrecht, Gerald L. Denardo
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 902–903.
Published: 01 May 2005
View article titled, Development of synthetic high affinity ligands that bind to a structural epitope on the tumor cell receptor HLA-DR10